Application 761113
- Type
- BLA
- Sponsor
- SANOFI AVENTIS US
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761113 | Sarclisa | isatuximab-irfc | 351(a) | Rx | 2026-08-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SARCLISA | ISATUXIMAB-IRFC | INJECTABLE;INJECTION | 100MG/5ML (20MG/ML) | No | No |
| 002 | SARCLISA | ISATUXIMAB-IRFC | INJECTABLE;INJECTION | 500MG/25ML (20MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sarclisa | ISATUXIMAB | Sanofi-Aventis U.S. LLC | a0473462-6f9d-4eca-a5bf-8620aea68e8a | 2026-07-07 | Warnings, Adverse reactions | BLA761113 0024-0656 0024-0654 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0024-0654 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0654 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0654 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0654 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0656 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0656 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0656 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
| 0024-0656 | Sarclisa | isatuximab | sanof-aventis U.S. LLC | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80034 | SUPPL | 2024-10-29 |
| 80033 | SUPPL | 2024-10-29 |
| 80029 | SUPPL | 2024-10-28 |
| 80028 | SUPPL | 2024-10-28 |
| 79722 | SUPPL | 2024-09-24 |
| 79674 | SUPPL | 2024-09-20 |
| 76036 | SUPPL | 2023-11-02 |
| 76033 | SUPPL | 2023-11-02 |
| 71596 | SUPPL | 2022-07-19 |
| 71584 | SUPPL | 2022-07-18 |
| 66939 | SUPPL | 2021-04-01 |
| 66935 | SUPPL | 2021-03-31 |
| 66816 | SUPPL | 2021-03-19 |
| 66813 | SUPPL | 2021-03-19 |
| 62313 | ORIG | 2020-03-25 |
| 62020 | ORIG | 2020-03-04 |
| 62005 | ORIG | 2020-03-02 |